Mark W Hahn Verona Pharma PLC (VRNA) insider trading activity

Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 13.3 Million shares of VRNA, which is worth approximately $601 Million. The most recent transaction as insider was on Dec 06, 2024, when has been sold 183,728 shares (Ordinary Shares) at a price of $5.01 per share, resulting in proceeds of $920,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3M

7.29% 3M change

14.3% 12M change

Total Value Held $601 Million

Mark W Hahn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 06 2024	SELL Open market or private sale	$920,477 $5.01 p/Share	183,728 Reduced 1.36%	13,293,736 Ordinary Shares
Dec 05 2024	SELL Open market or private sale	$3,206,640 $5.01 p/Share	640,048 Reduced 4.53%	13,477,464 Ordinary Shares
Dec 04 2024	SELL Open market or private sale	$290,920 $5.0 p/Share	58,184 Reduced 0.41%	14,117,512 Ordinary Shares
Dec 02 2024	SELL Open market or private sale	$8,000 $5.0 p/Share	1,600 Reduced 0.01%	14,175,696 Ordinary Shares
Nov 29 2024	SELL Open market or private sale	$494,507 $5.01 p/Share	98,704 Reduced 0.69%	14,177,296 Ordinary Shares
Nov 27 2024	SELL Open market or private sale	$64,680 $5.0 p/Share	12,936 Reduced 0.09%	14,276,000 Ordinary Shares
Nov 26 2024	SELL Open market or private sale	$4,000 $5.0 p/Share	800 Reduced 0.01%	14,288,936 Ordinary Shares
Nov 25 2024	SELL Open market or private sale	$8,000 $5.0 p/Share	1,600 Reduced 0.01%	14,289,736 Ordinary Shares
Nov 11 2024	SELL Open market or private sale	$12,000 $5.0 p/Share	2,400 Reduced 0.02%	14,291,336 Ordinary Shares
Nov 04 2024	SELL Open market or private sale	$354,641 $4.39 p/Share	80,784 Reduced 0.56%	14,293,736 Ordinary Shares
Nov 01 2024	SELL Open market or private sale	$214,129 $4.38 p/Share	48,888 Reduced 0.34%	14,374,520 Ordinary Shares
Nov 01 2024	SELL Payment of exercise price or tax liability	$1,042,836 $4.24 p/Share	245,952 Reduced 1.68%	14,423,408 Ordinary Shares
Nov 01 2024	BUY Grant, award, or other acquisition	-	200,000 Added 1.35%	14,669,360 Ordinary Shares
Oct 30 2024	BUY Grant, award, or other acquisition	-	800,000 Added 5.24%	14,469,360 Ordinary Shares
Oct 25 2024	SELL Open market or private sale	$14,016 $4.38 p/Share	3,200 Reduced 0.02%	13,669,360 Ordinary Shares
Oct 24 2024	SELL Open market or private sale	$619,156 $4.38 p/Share	141,360 Reduced 1.02%	13,672,560 Ordinary Shares
Oct 22 2024	SELL Open market or private sale	$697,926 $4.38 p/Share	159,344 Reduced 1.14%	13,813,920 Ordinary Shares
Oct 21 2024	SELL Open market or private sale	$511,128 $4.38 p/Share	116,696 Reduced 0.83%	13,973,264 Ordinary Shares
Oct 18 2024	SELL Open market or private sale	$1,093,808 $4.38 p/Share	249,728 Reduced 1.74%	14,089,960 Ordinary Shares
Sep 11 2024	SELL Open market or private sale	$2,256,000 $3.76 p/Share	600,000 Reduced 4.02%	14,339,688 Ordinary Shares
Aug 13 2024	SELL Open market or private sale	$1,286,832 $3.23 p/Share	398,400 Reduced 2.6%	14,939,688 Ordinary Shares
Aug 12 2024	SELL Open market or private sale	$5,008 $3.13 p/Share	1,600 Reduced 0.01%	15,338,088 Ordinary Shares
Aug 07 2024	SELL Payment of exercise price or tax liability	$824,776 $2.62 p/Share	314,800 Reduced 2.01%	15,339,688 Ordinary Shares
Aug 07 2024	BUY Grant, award, or other acquisition	-	800,000 Added 4.86%	15,654,488 Ordinary Shares
Aug 01 2024	SELL Payment of exercise price or tax liability	$250,579 $2.83 p/Share	88,544 Reduced 0.59%	14,854,488 Ordinary Shares

MWH

Mark W Hahn

Chief Financial Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account